AUTL
Autolus Therapeutics Plc
NASDAQ · Healthcare · Biotechnology · GB
$1.94
+1.04%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.13x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.90x
- Price / sales
- 4.40x
- Price / cash flow
- -2.29x
Enterprise value
- Enterprise value
- $398.2M
- EV / sales
- 3.39x
- EV / EBITDA
- -1.80x
- EV / EBIT
- -1.61x
- Market cap
- $516.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026